Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies

Abstract

Gonadal and sexual function are key to quality of life following bone marrow transplantation (BMT), but no large studies have been published on Leydig cell (LC) function in adults. LC insufficiency (LCI) can cause premature andropause with its consequences including sexual morbidity from diminished libido and erectile dysfunction (ED). In addition, LCI can result in generalised fatigue and even osteopenia. We reviewed gonadal function pre-transplant (immediately prior to BMT) and at 3–18 months post BMT in 117 patients who underwent BMT for a variety of haematological malignancies. The patients presented with variable degrees of symptoms of LCI, such as fatigue, diminished sex drive and libido or ED. The results suggest that the patients sustained severe gonadal damage to both their germ cells (GC) as well as the LC compartment (P < 0.001). We characterised two distinct functional subsets of LC insufficiency: Type I: compensated type with high LH and normal T levels and low T/LH ratio: (n = 102); and type II: uncompensated type (premature andropause) with high LH and low testosterone levels with low T/LH ratio (n = 15). Although type II patients had more severe LC damage than type I, patients in both groups were symptomatic. We recommend that symptomatic patients in both groups may benefit from a therapeutic trial with testosterone replacement treatment (TRT) for 3–6 months. Bone Marrow Transplantation (2001) 28, 497–502.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Litwin MS, Lubeck DP, Stoddard ML et al. Quality of life before death for men with prostate cancer: results from the CaPSURE database J Urol 2001 165: 871–875

    Article  CAS  PubMed  Google Scholar 

  2. Zittoun R, Suciu S, Watson M et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial Bone Marrow Transplant 1997 20: 307–315

    Article  CAS  PubMed  Google Scholar 

  3. Howell S, Shalet SM . Gonadal damage from chemotherapy and radiotherapy Endocrinol Metab Clin North Am 1998 27: 927–943

    Article  CAS  PubMed  Google Scholar 

  4. Chatterjee R, Goldstone AH . Gonadal damage and effects on fertility after bone marrow transplantation Bone Marrow Transplant 1996 17: 5–11

    CAS  PubMed  Google Scholar 

  5. Mertens AC, Ramsay NK, Kouris S, Neglia JP . Patterns of gonadal dysfunction following bone marrow transplantation Bone Marrow Transplant 1998 22: 345–350

    Article  CAS  PubMed  Google Scholar 

  6. Chatterjee R, Mills W, Katz M et al. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma Bone Marrow Transplant 1994 13: 519–522

    CAS  PubMed  Google Scholar 

  7. Brennemann W, Stoffel-Wagner B, Helmers et al. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer J Urol 1997 158: 844–850

    Article  CAS  PubMed  Google Scholar 

  8. Wichers M, Benz E, Palmedo H et al. Testicular function after radioiodine therapy for thyroid carcinoma Eur J Nucl Med 2000 27: 503–507

    Article  CAS  PubMed  Google Scholar 

  9. Shalet SM . Effect of irradiation treatment on gonadal function in men treated for germ cell cancer Eur Urol 1993 23: 148–151

    Article  CAS  PubMed  Google Scholar 

  10. Plymate ST . Male hypogonadism In: Becker KL (ed.) Principle and Practice of Endocrinology and Metabolism JB Lippincott Co: Philadelphia 1995; pp 1056–1083

    Google Scholar 

  11. Vermeulen A, Kaufman JM . Ageing of the hypothalamo–pituitary–testicular axis in men Horm Res 1995 43: 25–28

    Article  CAS  PubMed  Google Scholar 

  12. Gurenewals DA, Matsumoto AM . Ageing and endocrinology In: Becker KL (ed.) Principle and Practice of Endocrinology and Metabolism JB Lippincott Co.: Philadelphia 1995 pp 1664–1679

    Google Scholar 

  13. Viviani S, Ragni G, Santoro et al. Testicular dysfunction in Hodgkin's disease before and after treatment Eur J Cancer 1991 27: 1389–1392

    Article  CAS  PubMed  Google Scholar 

  14. Barr RD, Clark DA, Booth JD . Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder Med Hypotheses 1993 40: 165–168

    Article  CAS  PubMed  Google Scholar 

  15. Pryzant RM, Meistrich ML, Wilson G et al. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas J Clin Oncol 1993 11: 239–247

    Article  CAS  PubMed  Google Scholar 

  16. Young CK . Testosterone supplementation in the ageing male Int J Inpot Res 1999 13: 343–352

    Google Scholar 

  17. Rivkees SA, Crawford JD . The relationship of gonadal activity and chemotherapy-induced gonadal damage JAMA 1988 259: 2123–2125

    Article  CAS  PubMed  Google Scholar 

  18. Marmor D, Duyck F . Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey Andrologia 1995 27: 99–106

    Article  CAS  PubMed  Google Scholar 

  19. Wallace WH, Shalet SM, Crowne EC et al. Gonadal dysfunction due to cis-platinum Med Pediatr Oncol 1989 17: 409–413

    Article  CAS  PubMed  Google Scholar 

  20. Shalet SM, Tsatsoulis A, Whitehead E, Read G . Vulnerability of the human Leydig cell to radiation damage is dependent upon age J Endocrinol 1989 120: 161–165

    Article  CAS  PubMed  Google Scholar 

  21. Aversa A, Isidori AM, De Martino MU et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction Clin Endocrinol 2000 53: 517–522

    Article  CAS  Google Scholar 

  22. Jannini EA, Screponi E, Carosa E et al. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone Int J Androl 1999 22: 385–392

    Article  CAS  PubMed  Google Scholar 

  23. Jain P, Rademaker AW, McVary KT . Testosterone supplementation for erectile dysfunction: results of a meta-analysis J Urol 2000 164: 371–375

    Article  CAS  PubMed  Google Scholar 

  24. Chatterjee R, Andrews HO, McGarrigle HH et al. Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies Bone Marrow Transplant 2000 25: 1185–1189

    Article  CAS  PubMed  Google Scholar 

  25. Tenover JL . Male hormone replacement therapy including ‘andropause’ Endoc Metab Clin North Am 1998 27: 969–987

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatterjee, R., Kottaridis, P., McGarrigle, H. et al. Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies. Bone Marrow Transplant 28, 497–502 (2001). https://doi.org/10.1038/sj.bmt.1703160

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703160

Keywords

This article is cited by

Search

Quick links